Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Vascular Effects Vascular effects include: Angiogenesis Promotion Through VEGF and bFGF expression at 1 nM concentration Improved Blood Vessel Integrity Through collagen and elastin synthesis in vessel walls SPARC Protein Release Released during injury stimulates vessel growth and repair Enhanced Microcirculation Improved blood flow to peripheral tissues Anticoagulation Properties Demonstrated effects on blood clotting factors Restored Blood Flow To damaged tissues enhancing healing capacity Injectable Dosing Protocols and Administration Injectable GHK-Cu protocols typically use carefully calibrated dosing based on decades of research and clinical experience
Human Evidence and Safety Human Studies: Only two very small pilot studies in humans exist (one for bladder pain, one for knee pain, each with fewer than 20 participants)7
Google searches for GHK-Cu spiked massively in 2025 and have remained elevated
First isolated from human plasma, the tripeptide binds Cu with high affinity and acts as a copper carrier, delivering the metal into cells in a redox-controlled form
A 0.027% dose is on the lower end of what research shows to be effective
Preclinical studies highlight their complementary actions in enhancing recovery and reducing scarring
US$ 25.90
US$ 27.94
US$ 25.61
US$ 26.71
US$ 26.68
US$ 23.54
US$ 24.23
